U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Safety & Availability (Biologics)
  4. Pandemic Influenza Information
  1. Safety & Availability (Biologics)

Pandemic Influenza Information

Pandemic influenza (flu) is a significant global public health threat. Preparedness has been recognized as a critical local, national and worldwide priority. CBER plays a critical role in fostering the development and increasing the availability of and access to safe and effective biological products to preserve public health by controlling this and other emerging infectious disease threats to public health.

General Information

Commenting to the Docket

Product Development and Approval

Back to Top